Showing results (1-10 of 459) with videos related to
Sort By:
Pageof 46
The American Journal of Medicine|April 4, 2020
Catch of the Day: Icosapent Ethyl for Reducing Cardiovascular RiskDave L DixonThe American Journal of Managed Care|December 9, 2022
The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care implicationsDave L DixonCardiovascular Diabetology|May 30, 2019
The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitusSalvatore Carbone, Dave L DixonThe Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|April 8, 2014
Considerations for dofetilide use in the elderlyLindsey W Crist, Dave L DixonJournal of Blood Medicine|July 18, 2015
Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolismKelechi C Ogbonna, Dave L DixonPharmacotherapy|August 25, 2021
Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular diseaseArden R Barry, Dave L DixonPharmacotherapy|May 30, 2009
Interaction between gemfibrozil and warfarin: case report and review of the literatureDave L Dixon, Virginia G WilliamsAmerican Journal of Pharmaceutical Education|July 24, 2021
Long-term Association of Altmetric Attention Scores With Citations in Selected Major Pharmacy JournalsDave L Dixon, William L BakerJournal of the American Pharmacists Association : Japha|January 1, 2021
Pharmacist-administered long-acting injectable PCSK9 service: A solution to improve patient access and adherenceDave L Dixon, Joseph J SaseenJournal of Clinical Lipidology|May 9, 2026
Nonstatins for LDL-C lowering: An expansion whose time has comeJoseph J Saseen, Dave L DixonPageof 46